Cargando…

Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region

IgG4s are dynamic molecules that undergo a process called Fab-arm exchange. Disulfide bonds between heavy chains are transiently reduced, resulting in half antibodies that reform intact antibodies with other IgG4 half antibodies. In vivo, therapeutic IgG4s can recombine with endogenous IgG4s, result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Handlogten, Michael W., Peng, Li, Christian, Elizabeth A., Xu, Weichen, Lin, Shihua, Venkat, Raghavan, Dall’Acqua, William, Ahuja, Sanjeev
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531514/ https://www.ncbi.nlm.nih.gov/pubmed/32633193 http://dx.doi.org/10.1080/19420862.2020.1779974

Ejemplares similares

Mechanistic modeling of a human IgG(4) monoclonal antibody (tralokinumab) Fab‐arm exchange with endogenous IgG(4) in healthy volunteers
por: Wang, Bing, et al.
Publicado: (2022)

Fab-arm exchange is a misnomer
por: Pandey, Janardan P.
Publicado: (2012)

Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange
por: Rispens, Theo, et al.
Publicado: (2014)

Fab-arm exchange: What’s in a name?
por: Schuurman, Janine, et al.
Publicado: (2012)

Production of stable bispecific IgG1 by controlled Fab-arm exchange: Scalability from bench to large-scale manufacturing by application of standard approaches
por: Gramer, Michael J, et al.
Publicado: (2013)

Coming together at the hinges: Therapeutic prospects of IgG3
por: Chu, Thach H., et al.
Publicado: (2021)

Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
por: Chu, Thach H., et al.
Publicado: (2020)

Enhancement of Immune Effector Functions by Modulating IgG’s Intrinsic Affinity for Target Antigen
por: Mazor, Yariv, et al.
Publicado: (2016)

In vitro Fab display: a cell-free system for IgG discovery
por: Stafford, Ryan L., et al.
Publicado: (2014)

Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains
por: Benedetti, Filippo, et al.
Publicado: (2021)

Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities
por: Yanakieva, Desislava, et al.
Publicado: (2022)

Staphylococcus pseudintermedius Sbi paralogs inhibit complement and bind IgM, IgG Fc and Fab
por: Sewid, Alaa H., et al.
Publicado: (2019)

Regulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen
por: Wang, Bo, et al.
Publicado: (2019)

Generation and Characterization of an IgG4 Monomeric Fc Platform
por: Shan, Lu, et al.
Publicado: (2016)

IgG anti-hinge antibodies against IgG4 F(ab’)(2) fragments generated using pepsin are useful diagnostic markers for rheumatoid arthritis: implications of the possible roles of metalloproteinases and IgG subclasses in generating immunogenic hinge epitopes
por: Ota, Toshiyuki, et al.
Publicado: (2020)

Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression
por: Buchanan, Andrew, et al.
Publicado: (2013)

Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3)
por: Plomp, Rosina, et al.
Publicado: (2015)

The Origins, Specificity, and Potential Biological Relevance of Human Anti-IgG Hinge Autoantibodies
por: Brezski, Randall J., et al.
Publicado: (2011)

Biophysical Characterization of the Contribution of the Fab Region to the IgG-FcγRIIIa Interaction
por: Kosuge, Hirofumi, et al.
Publicado: (2022)

Solution structures of human myeloma IgG3 antibody reveal extended Fab and Fc regions relative to the other IgG subclasses
por: Spiteri, Valentina A., et al.
Publicado: (2021)

Identification and quantitation of hinge cysteinylation on endogenous IgG2 antibodies from human serum
por: Ayalew, Luladey, et al.
Publicado: (2020)

Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
por: Maun, Henry R., et al.
Publicado: (2020)

Enterococcus faecalis Endocarditis Severity in Rabbits Is Reduced by IgG Fabs Interfering with Aggregation Substance
por: Schlievert, Patrick M., et al.
Publicado: (2010)

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement
por: Brinkhaus, Maximilian, et al.
Publicado: (2022)

IgG Antibodies to Cyclic Citrullinated Peptides Exhibit Profiles Specific in Terms of IgG Subclasses, Fc-Glycans and a Fab-Peptide Sequence
por: Lundström, Susanna L., et al.
Publicado: (2014)

IgG1 and IgG4 antibodies sample initial structure dependent local conformational states and exhibit non-identical Fab dynamics
por: Natesan, Ramakrishnan, et al.
Publicado: (2023)

Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodies
por: Goulet, Dennis R., et al.
Publicado: (2018)

Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys
por: Losen, Mario, et al.
Publicado: (2017)

Non-covalent Fc-Fab interactions significantly alter internal dynamics of an IgG1 antibody
por: Natesan, Ramakrishnan, et al.
Publicado: (2022)

Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?
por: Pisil, Yalcin, et al.
Publicado: (2021)

Engineering the hinge region of human IgG1 Fc-fused bispecific antibodies to improve fragmentation resistance
por: Suzuki, Saori, et al.
Publicado: (2018)

Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells
por: Kiefer, Maximilian, et al.
Publicado: (2022)

Construction of IgG–Fab(2) bispecific antibody via intein-mediated protein trans-splicing reaction
por: Yamada, Risa, et al.
Publicado: (2023)

Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in binding
por: Oganesyan, Vaheh, et al.
Publicado: (2015)

Improving target cell specificity using a novel monovalent bispecific IgG design
por: Mazor, Yariv, et al.
Publicado: (2015)

Effects of antibody disulfide bond reduction on purification process performance and final drug substance stability
por: Chung, Wai Keen, et al.
Publicado: (2017)

Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge
por: Stapleton, Nigel M., et al.
Publicado: (2019)

Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization
por: Mitropoulou, Alkistis N., et al.
Publicado: (2020)

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).
por: Antoniw, P., et al.
Publicado: (1996)

Data of rational process optimization for the production of a full IgG and its Fab fragment from hybridoma cells
por: Röhm, Martina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6t3p6csv9un3bqsj80opop6kam